Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Amoxicillin Sodium and Sulbactam Sodium for Injection

Approval Number

国药准字H20040294

Company华北制药股份有限公司

Registration Date

April 21, 2020

Drug Information

Generic Name

注射用阿莫西林钠舒巴坦钠

Trade Name

倍舒林

Brand Name

倍舒林

Dosage Form

注射剂

Strength

0.375g(C16H19N3O5S 0.25g与C8H11NO5S 0.125g)

Drug Type

化学药品

Registration Date

April 21, 2020

Company Information

Applicant Company

Company Name华北制药股份有限公司

Manufacturing Company

Company Name华北制药股份有限公司

Company Address

石家庄市和平东路388号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy